PTSD Trial, Recruiting (NCT04670640)

PTSD Trial, Recruiting NCT04670640 Sponsor: Emory University Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT04670640 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have experienced at least one traumatic event that meets a specific clinical definition of trauma (assessed using a checklist of life events)
People who score 7 or higher on a standardised scale that measures feelings of depersonalisation (a sense of feeling detached from oneself)
People who are willing to take part in the study

Who may not be able to join:

People who are currently experiencing active psychosis or significant cognitive impairment, as assessed using a standard screening tool
People with moderate or severe dependence on alcohol or other substances, as assessed using a clinical interview tool
People who are considered to be at immediate risk of harming themselves or others

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Negar Fani, PhD, Emory University

Phone: 404-712-0354

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04670640

Sponsor: Emory University

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

Trial contact: 404-712-0354

More information: https://clinicaltrials.gov/study/NCT04670640

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have experienced at least one traumatic event that meets a specific clinical definition of trauma (assessed using a checklist of life events)
People who score 7 or higher on a standardised scale that measures feelings of depersonalisation (a sense of feeling detached from oneself)
People who are willing to take part in the study

Who may not be able to join:

People who are currently experiencing active psychosis or significant cognitive impairment, as assessed using a standard screening tool
People with moderate or severe dependence on alcohol or other substances, as assessed using a clinical interview tool
People who are considered to be at immediate risk of harming themselves or others

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Emory University

Registry

ClinicalTrials.gov

Start date

18 September 2021

Est. completion

1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Clinician Administered Post Traumatic Stress Disorder (PTSD) Scale (CAPS) Score; Change in Mini International Neuropsychiatric Interview (MINI) Diagnosis of Psychiatric Disorders; Change in Multiscale Dissociation Inventory (MDI) Score; Change in Kentucky Mindfulness Scale (KIMS) Score; Change in Multidimensional Assessment of Interoceptive Awareness (MAIA) Score; Change in Attentional Control Scale (ACS) Score; Change in Difficulties in Emotion Regulation Scale (DERS) Score; Change in PTSD Symptom Checklist (PCL-5) Score; Change in Change in Life Events Checklist Score; Change in Se...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov